Isabella Rossi 11/27/23 Isabella Rossi 11/27/23

Elon Musk and Russell Brand in Moderna's Crosshairs: The Crusade Against Vaccine Dissent

Read More

Mark Armstrong 10/13/23 Mark Armstrong 10/13/23

The Great Pfizer Crash: Sky-High Ambitions Now in Free Fall

Read More

David Stone 10/12/23 David Stone 10/12/23

Potential Deal Brewing: Gritstone's Game-Changing Vaccine in the Spotlight

Read More

Mark Armstrong 10/11/23 Mark Armstrong 10/11/23

Gritstone Bio Unveils Game-Changing COVID-19 Vaccine Results

Read More

David Stone 10/4/23 David Stone 10/4/23

How High Could the Stock Price of Gritstone Bio Go?

Read More

David Stone 10/1/23 David Stone 10/1/23

Gritstone Bio to Present What is Likely Spectacular Data at ID Week

Read More

David Stone 9/28/23 David Stone 9/28/23

The Next Moderna? How Gritstone Bio Could Dominate the Vaccine Industry

Read More

David Stone 8/19/23 David Stone 8/19/23

New Highly Mutated Covid-19 Variant BA.2.86 Detected in Multiple Countries

Read More

Mark Armstrong 5/15/23 Mark Armstrong 5/15/23

10 Reasons to Invest in Moderna: A Biotech Powerhouse

Read More

Derek Slater 3/22/23 Derek Slater 3/22/23

Moderna's $130 COVID-19 Vaccine Price Tag Raises Concerns as Commercial Distribution Approaches

Read More

Mark Armstrong 12/28/22 Mark Armstrong 12/28/22

New Chinese Covid Variants Could Drastically Affect the Stock Market in 2023

Read More

David Stone 10/28/22 David Stone 10/28/22

3 reasons to sell BioNTech and buy Moderna

Read More

David Stone 7/25/22 David Stone 7/25/22

US Government plans to fund next generation Covid-19 vaccines

Read More

David Stone 4/21/22 David Stone 4/21/22

BioNTech’s Deal with Matinas Could Put Moderna Out of Business

Read More

David Stone 8/29/21 David Stone 8/29/21

Vaccinate Immediately if You Want to Travel in The Next Six Months

Read More